Breast cancer
Conditions
Interventions
Gold Standard:Pathological diagnosis
clinical outcome
Index test:ncRNAs Panel
Sponsors
Shanghai Tenth People's Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Female patients >=18 years old and = 1.5 x 10^9/L; Platelet count (PLT) >= 90 x 10^9/L; Hemoglobin (Hb) >= 90 g/L; 2) Blood biochemistry: Total bilirubin (TBIL) <= 1.5 x upper limit of normal (ULN); Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) <= 1.5 x ULN; Alkaline phosphatase <= 2.5 x ULN; Urea or urea nitrogen (BUN) and creatinine (Cr)<= 1.5 x ULN; 3) 12-lead ECG: QT interval (QTcF) corrected by Fridericia method < 470 msec. 8. Volunteer to join the study, sign an informed consent form, have good compliance and are willing to cooperate with follow-up.
Exclusion criteria
Exclusion criteria: 1. The history of any malignant tumor other than breast cancer in the past 5 years, excluding cured cervical carcinoma in situ, skin basal cell carcinoma or squamous cell carcinoma; 2. Suffer from serious concomitant diseases or other comorbid diseases that will interfere with planned treatment, including infectious diseases with active infections (including but not limited to hepatitis B, active hepatitis C, active tuberculosis, active syphilis, etc.), Or the investigator believes that the patient is not suitable for any other situation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival;Progression Free Survival;tumor control probability;Adverse Event;SEN, SPE, ACC, AUC of ROC, PPV, NPV; | — |
Countries
China
Contacts
Public ContactLin Fang
Shanghai Tenth People's Hospital
Outcome results
None listed